Log on / register
BioMed Central home | Journals A-Z | Feedback | Support | My details
Serum levels of biomarkers of bone and cartilage destruction and new bone formation in different cohorts of patients with axial spondyloarthritis with and without tumor necrosis factor-alpha blocker treatment.
Appel H, Janssen L, Listing J, Heydrich R, Rudwaleit M, Sieper J
Arthritis Res Ther 2008, 10:R125
[Full text] [PubMed] [Related articles] [Cited on BioMed Central]


printer friendly 
to  [Help]

BioMed Central articles that cite the above article:

1.


Review    
Progress in spondylarthritis. Mechanisms of new bone formation in spondyloarthritis
Lories RJU, Luyten FP, de Vlam K
Arthritis Research & Therapy 2009, 11:221 (27 April 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles]
2.


Editorial    
What do biomarkers tell us about the pathogenesis of ankylosing spondylitis?
Maksymowych WP
Arthritis Research & Therapy 2009, 11:101 (7 January 2009)
 [Abstract] [Full text] [PDF] [PubMed] [Related articles] [Cited on BioMed Central]

You can also check ISI Web of Science for additional citations (subscription required)
printer friendly 
to  [Help]
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.